tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market
LCTX
Lineage Therap
RESEARCH TOOLSreports
Want to see LCTX full AI Analyst Report?

Lineage Therap (LCTX) Income Statement

2,048 Followers

Lineage Therap Income Statement

Last quarter (Q4 2025), Lineage Therap's total revenue was $6.61M, an increase of 130.40% from the same quarter last year. In Q4, Lineage Therap's net income was $851.00K. See Lineage Therap’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.56M$ 9.50M$ 8.95M$ 14.70M$ 3.90M
Gross Profit
$ 13.71M$ 9.16M$ 8.27M$ 13.97M$ 2.47M
Operating Expenses
$ 35.49M$ 30.64M$ 33.01M$ 36.49M$ 51.68M
Depreciation and Amortization
$ 699.00K$ 609.00K$ 692.00K$ 727.00K$ 873.00K
EBITDA
$ -21.08M$ -20.87M$ -24.04M$ -21.79M$ -48.34M
Operating Income
$ -21.78M$ -21.48M$ -24.73M$ -22.52M$ -49.21M
Other Income/Expenses
$ -46.87M$ 2.90M$ 1.45M$ -3.29M$ 5.94M
Pretax Income
$ -68.65M$ -18.58M$ -23.28M$ -25.81M$ -43.27M
Net Income
$ -63.53M$ -18.61M$ -21.49M$ -26.27M$ -43.02M
Per Share Metrics
Basic EPS
$ -0.28$ -0.09$ -0.12$ -0.15$ -0.26
Diluted EPS
$ -0.28$ -0.09$ -0.12$ -0.15$ -0.26
Weighted Average Shares Outstanding
 230.12M 200.19M 172.66M 169.79M 164.50M
Weighted Average Shares Outstanding (Diluted)
 230.12M 200.19M 172.66M 169.79M 164.50M
Currency in USD

Lineage Therap Earnings and Revenue History